Diagnosis and Management of Arrhythmogenic Right Ventricular Cardiomyopathy
Overview
Affiliations
Arrhythmogenic right ventricular cardiomyopathy (ARVC) is a genetic disorder of the myocardium that can lead to ventricular arrhythmia and sudden cardiac death. The condition has been identified as a significant cause of arrhythmic death among young people and athletes, therefore, early recognition of the disease by emergency clinicians is critical to prevent subsequent death. The diagnosis of ARVC can be very challenging and requires a systematic approach. This publication reviews the pathophysiology, classification, clinical presentations, and appropriate approach to diagnosis and management of ARVC.
Sudden Cardiac Death in the Young: State-of-the-Art Review in Molecular Autopsy.
Salzillo C, Sansone V, Napolitano F Curr Issues Mol Biol. 2024; 46(4):3313-3327.
PMID: 38666937 PMC: 11049009. DOI: 10.3390/cimb46040207.
Khan F, Memon S, Sajjad W Cureus. 2024; 16(3):e56709.
PMID: 38646239 PMC: 11032644. DOI: 10.7759/cureus.56709.
Krüpple-like factors in cardiomyopathy: emerging player and therapeutic opportunities.
Gui L, Liu H, Jin L, Peng X Front Cardiovasc Med. 2024; 11:1342173.
PMID: 38516000 PMC: 10955087. DOI: 10.3389/fcvm.2024.1342173.
Wang M, Xu X, Li J, Gao Z, Ding Y, Chen X Aging (Albany NY). 2023; 15(23):14210-14241.
PMID: 38085668 PMC: 10756114. DOI: 10.18632/aging.205298.
Antiarrhythmic Drug Therapy in Arrhythmogenic Right Ventricular Cardiomyopathy.
Gaine S, Calkins H Biomedicines. 2023; 11(4).
PMID: 37189831 PMC: 10136163. DOI: 10.3390/biomedicines11041213.